home / stock / raonf / raonf short
Short Information | Race Oncology (OTCMKTS:RAONF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 10,710 |
Total Actual Volume | 10,710 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 4 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 536 |
Average Short Percentage | 20.00% |
Is there a RAONF Short Squeeze or Breakout about to happen?
See the RAONF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-01-2021 | $2.6 | $2.6 | $2.6 | $2.6 | 1,150 | 1,150 | 100% |
10-27-2021 | $2.5 | $2.5 | $2.5 | $2.5 | 780 | 780 | 100% |
10-05-2021 | $2.39 | $2.39 | $2.39 | $2.39 | 780 | 780 | 100% |
07-16-2021 | $2.69 | $2.69 | $2.69 | $2.69 | 8,000 | 8,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Race Oncology Company Name:
RAONF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Dr Daniel Tillett joins Proactive’s Jonathan Jackson to discuss promising preclinical findings. Research indicated that combining bisantrene with decitabine greatly enhances the destruction of cancer cells across a wide variety of...
(NewsDirect) Race Oncology Ltd (ASX:RAC) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the company’s movements over the last few months. Just recently, Race received a $4 million R&D tax incentive tto accelerate clinical development of bi...
(NewsDirect) Race Oncology Ltd (ASX:RAC) executive director Pete Smith speaks with Proactive alongside the company’s recently appointed CEO - 25-year veteran of the biotech space, Dr Daniel Tillett. In this pivotal role, Dr Tillett will work closely with Dr Smith to steer the company's...